scholarly journals Erratum to “Proportion of cervical excision for cervical intraepithelial neoplasia as a predictor of pregnancy outcomes”[Int J Gynecol Obstet 128(2015) 141–147]

2019 ◽  
Vol 146 (3) ◽  
pp. 392-392
Author(s):  
Maria Kyrgiou ◽  
George Valasoulis ◽  
Sofia‐Melina Stasinou ◽  
Christina Founta ◽  
Antonios Athanasiou ◽  
...  
2014 ◽  
Vol 128 (2) ◽  
pp. 141-147 ◽  
Author(s):  
Maria Kyrgiou ◽  
George Valasoulis ◽  
Sofia-Melina Stasinou ◽  
Christina Founta ◽  
Antonios Athanasiou ◽  
...  

2019 ◽  
Vol 148 (1) ◽  
pp. 133-133
Author(s):  
Giorgio Bogani ◽  
Maurizio Serati ◽  
Umberto Leone Roberti Maggiore ◽  
Antonino Ditto ◽  
Barbara Gardella ◽  
...  

BMJ ◽  
2014 ◽  
Vol 349 (oct28 1) ◽  
pp. g6192-g6192 ◽  
Author(s):  
M. Kyrgiou ◽  
A. Mitra ◽  
M. Arbyn ◽  
S. M. Stasinou ◽  
P. Martin-Hirsch ◽  
...  

2013 ◽  
Vol 23 (4) ◽  
pp. 710-715 ◽  
Author(s):  
Rekha Wuntakal ◽  
Alejandra Castanon ◽  
Peter D. Sasieni ◽  
Antony Hollingworth

BMJ Open ◽  
2019 ◽  
Vol 9 (10) ◽  
pp. e028009 ◽  
Author(s):  
Antonios Athanasiou ◽  
Areti Angeliki Veroniki ◽  
Orestis Efthimiou ◽  
Ilkka Kalliala ◽  
Huseyin Naci ◽  
...  

IntroductionThere are several local treatment methods for cervical intraepithelial neoplasia that remove or ablate a cone-shaped part of the uterine cervix. There is evidence to suggest that these increase the risk of preterm birth (PTB) and that this is higher for techniques that remove larger parts of the cervix, although the data are conflicting. We present a protocol for a systematic review and network meta-analysis (NMA) that will update the evidence and compare all treatments in terms of fertility and pregnancy complications.Methods and analysisWe will search electronic databases (CENTRAL, MEDLINE, EMBASE) from inception till October 2019, in order to identify randomised controlled trials (RCTs) and cohort studies comparing the fertility and pregnancy outcomes among different excisional and ablative treatment techniques and/or to untreated controls. The primary outcome will be PTB (<37 weeks). Secondary outcomes will include severe or extreme PTB, prelabour rupture of membranes, low birth weight (<2500 g), neonatal intensive care unit admission, perinatal mortality, total pregnancy rates, first and second trimester miscarriage. We will search for published and unpublished studies in electronic databases, trial registries and we will hand-search references of published papers. We will assess the risk of bias in RCTs and cohort studies using tools developed by the Cochrane collaboration. Two investigators will independently assess the eligibility, abstract the data and assess the risk of bias of the identified studies. For each outcome, we will perform a meta-analysis for each treatment comparison and an NMA once the transitivity assumption holds, using the OR for dichotomous data. We will use CINeMA (Confidence in Network meta-analysis) to assess the quality of the evidence for the primary outcome.Ethics and disseminationEthical approval is not required. Results will be disseminated to academic beneficiaries, medical practitioners, patients and the public.PROSPERO registration numberCRD42018115495


Sign in / Sign up

Export Citation Format

Share Document